Group subscription

Starting injectable medicine: How to prepare your T2DM patients

Starting injectable medicine: How to prepare your T2DM patients

Louise Roche Farmer

Sunday 1 August 2021, 01:00 AM
7 minutes to Read
Starting an injectable may feel like a huge leap for patients, but you can make it more acceptable by empowering patients/whānau with knowledge about their medicines
Starting an injectable may feel like a huge leap for patients, but you can make it more acceptable by empowering patients/whānau with knowledge about their medicines

Healthcare providers will already be familiar with insulin, currently the only injectable medicine for managing type 2 diabetes. However, dulaglutide, another injectable type 2 diabetes medicine will soon be available for initiation in primary care. As Louise Roche Farmer explains, it is important to build acceptability of injectable medicines early in the patient journey.

Key points, Providing patients and whānau with knowledge will help to build acceptability of their treatment. Most people with type 2 diabetes will require an i, Education Blue W/ Grey Background W/ Padding
References
  1. PHARMAC. Decision to fund two new medicines for type 2 diabetes. 2020. https://tinyurl.com/afcnmfpv
  2. Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab 2018;27(4):740–56.
  3. Brown E, Wilding JPH, Barber TM, et al. Weight loss variability with SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes mellitus and obesity: mechanistic possibilities. Obes Rev 2019;20:816–28.
  4. Eli Lilly and Company. Trulicity (dulaglutide) prescribing Information. US Food and Drug Administration. www.accessdata.fda.gov/drugsatfda_docs/label/2017/125469s007s008lbl.pdf Revised January 2017.
  5. Sparks L. Supporting patients to take the new diabetes meds: What you need to know. April 2021. https://tinyurl.com/HAHT2DMeds
  6. New Zealand Society for the Study of Diabetes. Type Two Diabetes Management Guidance. www.nzssd.org.nz
  7. Buse JB, Wexler DJ, Tsapas A, et al. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2020;63: 221–28.

Class

FRAZ Drug wastage

CLASStime: Medication wastage

In this article, Sue Frankland looks at the global problem of wastage of medications, including causes such as overprescribing and non-adherence. She also presents information from her master’s dissertation on how people understand, and respond to, medication expiration dates

Read more
Friday 1 March 2024, 12:35 AM
17 minutes to Read
More Class Articles